| abstract |
The invention relates to a composition, in particular a pharmaceutical preparation, preferably in the form of a liquid dose, which is suitable for the prophylactic or therapeutic treatment of in particular inflammatory diseases of the mouth and throat/pharyngeal cavity, wherein the composition contains, in combination and in respectively effective, in particular pharmaceutically active, quantities (a) marshmallow ( althaea officinalis L. ) and (b) polidocanol. |